What SignalChem does

SignalChem Biotech Inc. is a Richmond, British Columbia–based specialist in recombinant kinase and enzyme products for drug discovery research, founded in 2004 and operating with 101–250 employees. The company's core offering is a catalog of over 1,100 highly active kinases covering more than 90% of the human kinome, supplemented by 400+ clinically relevant mutant kinases spanning mutations of 70+ kinases, including on-target mutations that confer acquired drug resistance. These reagents are built on proprietary production and quality control platforms developed over 20+ years and are validated through 2,000+ citations in high-impact peer-reviewed journals.

SignalChem monetizes through two streams: catalog sales of kinase proteins, mutant kinases, kinase panels, phospho-specific antibodies, signaling proteins, substrates, and enzyme modulators, and fee-for-service custom enzyme and assay development plus compound screening and profiling work with a stated two-week turnaround. The customer base is horizontal — pharmaceutical and biotechnology companies running kinase drug discovery, academic laboratories studying signaling pathways, and contract research organizations performing selectivity profiling. Following the 2026 acquisition by Sino Biological Inc., SignalChem operates as a wholly-owned subsidiary serving as Sino Biological's Canada-based protein and enzyme CRO center, distributing through Sino Biological's global sales offices and 60+ country distributor network.

The company's go-to-market is sales-led, leveraging Sino Biological's direct sales force in the USA, Germany, Japan, and China, the global distributor network, an e-commerce storefront, scientific publication-driven credibility, trade show participation, and educational webinars. Certifications tied to Sino Biological's quality system include ISO 9001, ISO 13485, GMP, CMA, and CNAS. The intellectual property base is anchored in proprietary kinase production and assay platforms rather than in AI or computational tooling, with no disclosed AI/ML capabilities.

Name

SignalChem

Legal name

SignalChem Biotech Inc.

Website

https://signalchem.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

101–250 employees

Short description

SignalChem Biotech Inc. is a Canadian subsidiary of Sino Biological that develops and sells over 1,100 highly active kinases and 400+ clinically relevant mutant kinases, plus custom enzyme and assay CRO services, serving pharmaceutical, biotechnology, academic, and CRO customers in drug discovery research.

Ownership category

akta.pro rank

Product category

Life Science Research Reagents

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industry

Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)

Keywords

• Recombinant kinase proteins
• Enzyme drug discovery
• Cell signaling reagents
• Mutant kinase research
• Custom assay development

Headquarters

HQ city

Richmond

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain

Revenue model

1. Kinase and Enzyme Product Sales: Revenue generated from the sale of recombinant kinase proteins, enzyme products, and assay reagents. Products are sold through catalog offerings as well as custom orders, supporting drug discovery research and development activities in pharmaceutical and biotechnology companies.
2. Custom CRO Services: Fee-for-service revenue from custom enzyme development, assay development, and compound screening/profiling services. Services support kinase drug discovery from target discovery through lead optimization stages.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

SignalChem develops, produces, and sells recombinant kinase proteins and enzyme reagents for drug discovery research. The portfolio includes 1,100+ highly active kinases, 400+ clinically relevant mutant kinases, and supporting research reagents. The company also provides custom enzyme development, assay development, and compound screening/profiling services as a CRO supporting pharmaceutical and biotechnology customers.

Product overview

SignalChem Biotech is a specialized provider of kinase-related products and services for drug discovery research. The portfolio centers on over 1,100 highly active kinases covering more than 90% of the human kinome, supplemented by 400+ clinically relevant mutant kinases for studying drug resistance. These core protein products are supported by custom enzyme and assay development services, compound screening and profiling services, and complementary research reagents including phospho-specific antibodies, signaling proteins, substrates, and enzyme modulators. The products enable precision screening, profiling, and optimization workflows from target discovery through lead compound development.

Differentiator

Problem solved

Functional benefit

Products and services

• Active Kinases Over 1,100 highly active recombinant kinases covering more than 90% of the human kinome, designed for kinase screening and profiling applications in drug discovery research for pharmaceutical and biotechnology customers.
• Mutant Kinases Over 400 clinically relevant mutant kinases covering disease-associated mutants of 70+ kinases and on-target mutations conferring acquired resistance, used as a toolbox for investigating kinase mutations and drug resistance in cancer research.
• Custom Enzyme and Assay Development Custom enzyme development service offering proprietary production and quality control platforms for full-length/truncated and untagged/tagged enzymes, with multiple biochemical and cellular assay platforms supported by 20+ years of experience.
• Compound Screening and Profiling Services Tailored compound screening and profiling services with a two-week turnaround time, assessing compound selectivity, potency, kinetics, and mechanism of action to support initial screens, hit-to-lead, and lead optimization stages.
• Kinase Panels Comprehensive kinase panel toolkits covering various kinase families across the human kinome, providing a complete toolkit for accelerating selectivity profiling and kinase research.
• FDA-Approved Kinase Inhibitors Products Reference products covering FDA-approved kinase inhibitors with recommended products for each kinase target, supporting drug discovery and validation studies.
• Signaling Proteins Recombinant signaling proteins for studying cellular communication and therapeutic discovery, covering key signaling pathways.
• Phospho-Specific Antibodies Phospho-specific antibodies for studying signaling pathways and disease mechanisms, with custom service options available.
• Substrates and Assay Reagents Enzyme substrates and assay reagents for biochemical and cellular assay development in kinase research.
• Enzyme Inhibitors and Activators Modulators including enzyme inhibitors and activators for studying enzyme function and drug discovery applications.

Quantifiable outcome

• Cited in 2,000+ customer publications in high impact journals
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Sino Biological Inc.coreStrategic or Co-development PartnerSino Biological Inc. acquired SignalChem Biotech Inc. to strengthen its global presence and diversify its product offerings in the life science reagents market. The acquisition enhances Sino Biological's kinase drug discovery solutions portfolio and expands its Canadian CRO operations. SignalChem operates as a subsidiary within the Sino Biological group.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Bio-Techne: Bio-Techne offers a broad life science reagents portfolio including recombinant proteins, enzymes, and assay kits used in kinase and signaling research, with both catalog and custom offerings that compete with SignalChem.
• BPS Bioscience: BPS Bioscience specializes in recombinant enzymes, kinases, and assay kits for drug discovery, and provides custom enzyme production and screening services that directly overlap with SignalChem's core offering.
• ProQinase: ProQinase is a specialized kinase CRO providing recombinant kinase production, biochemical and cell-based kinase profiling, and custom assay development — a close functional peer to SignalChem's custom services.
• Cell Signaling Technology (CST): CST is a leading provider of kinase-related antibodies, recombinant proteins, and signaling pathway reagents, with a strong reputation in the same cell signaling research customer base SignalChem serves.
• Reaction Biology: Reaction Biology offers a broad catalog of kinases and profiling services, including selectivity screening and custom assay development for kinase drug discovery, mirroring SignalChem's services model.
• Eurofins DiscoverX: Eurofins DiscoverX offers a comprehensive portfolio of kinases, phosphatases, and other enzymes along with biochemical and cell-based assay services for drug discovery, making it one of the closest direct competitors to SignalChem in kinase reagents and CRO services.

Broad incumbents

• Thermo Fisher Scientific: Thermo Fisher is a global life sciences incumbent offering recombinant proteins, kinase assay kits, and drug discovery services through its Life Sciences and Pharma Services segments, competing with SignalChem in both catalog reagents and CRO services.
• Promega: Promega provides a broad portfolio of life science reagents, biochemical and cell-based assay kits, and custom services that overlap with SignalChem's enzyme and assay offerings, while serving a much larger customer base across multiple research areas.
• Merck KGaA (MilliporeSigma): MilliporeSigma supplies an extensive catalog of enzymes, kinases, and biochemical reagents along with drug discovery services, representing a broad incumbent presence in SignalChem's core markets.

Regional players

• Carna Biosciences: Carna Biosciences is a Japan-based provider of kinase proteins, profiling services, and kinase inhibitor screening, competing with SignalChem primarily in Asia and representing a regional peer in the same niche.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/signalchem

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SignalChem